Clinical Update: Highlighting the Outcome of a Clinical Trial with TCR-T targeting NYESO1
Time: 3:00 pm
day: Day Two
Details:
- Using small inhibitory RNA to downregulate the endogenous T cell receptors
- Clinical results of an investigator initiated in house manufactured clinical trial
- TCR T product showing efficacy targeting NYESO1
